Safety and dosing of bevacizumab (Avastin) for the treatment of recurrent respiratory papillomatosis

Simon R. Best, Aaron D. Friedman, Tali Landau-Zemer, Anca M. Barbu, James A. Burns, Mason W. Freeman, Yuan Di Halvorsen, Robert E. Hillman, Steven M. Zeitels*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

52 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and dosing of bevacizumab (Avastin) for the treatment of recurrent respiratory papillomatosis'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience